$ALZN 8-K SEC Filings

Filed On	Filing
29 Sep 2026	8-K: Regulation FD Disclosure DEPARTMENT OF RADIOLOGY Pharmacokinetics imaging of lithium at 7T – results from a phase 1/2A clinical trial with a novel organic lithium salt Massachusetts General Hospital HARVARD Medical School Ovidiu C. Andronesi , Katherine N. Maina...
03 Aug 2026	8-K: Entry into a Material Definitive Agreement; Notice of Delisting or Failure to Satisfy a Listing Rule +2 more
21 Jul 2026	8-K: Other Events
17 Apr 2026	8-K: Submission of Matters to a Vote of Security Holders
20 Mar 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
06 Mar 2026	8-K: Entry into a Material Definitive Agreement
18 Nov 2025	8-K: Other Events
14 Oct 2025	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
09 Oct 2025	8-K: Unregistered Sales of Equity Securities
25 Sep 2025	8-K: Unregistered Sales of Equity Securities
01 Aug 2025	8-K: Unregistered Sales of Equity Securities
23 Jul 2025	8-K: Results of Operations and Financial Condition
09 Jul 2025	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
08 May 2025	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Regulation FD Disclosure
25 Apr 2025	8-K: Submission of Matters to a Vote of Security Holders
03 Mar 2025	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
28 Feb 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
12 Dec 2024	8-K: Results of Operations and Financial Condition
15 Oct 2024	8-K: Regulation FD Disclosure
03 Oct 2024	8-K: Entry into a Material Definitive Agreement

Comments